Zyvox — Medica
Continuation of linezolid therapy
Initial criteria
- For Methicillin-Resistant Staphylococcus species infection, treatment – Approve for 1 month
- For Vancomycin-Resistant Enterococcus species infection, treatment – Approve for 1 month
- For continuation of linezolid therapy – Approve for 1 month if patient is transitioning from IV linezolid or IV vancomycin to oral linezolid therapy OR patient was started on oral linezolid in an inpatient facility and is continuing therapy
- For treatment of an infection that is resistant to other antibiotics but the organism is sensitive to linezolid – Approve for 1 month
- If there is insufficient information available to make a determination regarding coverage and the prescriber or representative cannot be contacted – Approve for up to 2 weeks of therapy
- For tuberculosis – Approve for 9 months if patient is age ≥ 18 years AND patient has extensively drug-resistant tuberculosis OR treatment-intolerant tuberculosis OR nonresponsive multidrug-resistant tuberculosis AND linezolid is prescribed in combination with Sirturo (bedaquiline) and Pretomanid
Approval duration
varies by indication (2 weeks, 1 month, or 9 months)